The market may not give a toss as you say but big pharma give, they give a big toss, hundreds of millions of $$$, even at pre clinical and phase 1 stages, our science is getting stronger each and every day, these deals below are cell therapy transactions...wait for the solid tumor deals that we're gonna be dancing with.
Looking forward to Imugene 2.0
Enjoy
December 19 - Acquisition by Xyphos Pre clinical upfront 120 million, 545 million milestone payment
June 21 - Acquisition by eterna Pre clinical 120 million upfront
May 21 - Acquisition by Athenex Phase 1, 70 million, 115 million milestone payment
August 21- Research collaboration by Gilead, Pre clinical total deal value $875 million
September 21- Development collaboration by Genentech, Pre clinical $150 million upfront, another $150 million milestone payment.
August 22 - Licence and strategic collaboration by Roche, Phase 1, $110 million upfront, $110 million milestone.
September 22 - Research collaboration by Genentech, pre clinical, $70 million upfront
October 22- Development collaboration by Gilead, Phase 2, $225 million upfront
January 23- Acquisition by Astra Zeneca, phase 1, $200 million upfront, $120 million milestone payment.
Ann: Imugene VAXINIA Trial clears Cohort 3 of IT Monotherapy, page-89
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.1¢ |
Change
-0.002(3.77%) |
Mkt cap ! $373.3M | |||
| Open | High | Low | Value | Volume |
| 5.2¢ | 5.2¢ | 5.0¢ | $669.7K | 13.07M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 1074997 | 5.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.2¢ | 1209633 | 6 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |